---
action_items:
- id: bc558ee67307
  severity: writing
  text: Claim 'largest image-tabular benchmarking effort to date' needs verification.
    Cite specific prior benchmarks with dataset counts (e.g., MuG, TIME, MultimodalTabPFN)
    to justify superlative. Abstract and Introduction, lines 1-15.
- id: 2a93acc9f453
  severity: writing
  text: Generalization claim 'gains generalize across learners, encoder scales, and
    dimensions' overstates scope. Only 5 learners, 2 encoder sizes (small/large),
    and 3 PCA dimensions tested. Qualify with 'across tested configurations' or expand
    evaluation. Section 5, lines 1-10.
- id: 0a49bd34f892
  severity: science
  text: Curation pipeline circularity understated. Datasets selected where TAR already
    outperforms frozen, then TAR gains reported. 'Entangles problem with solution'
    in Discussion (line 385) insufficient. Need explicit statement that benchmark
    validates TAR on datasets pre-selected for TAR-sensitivity. Section 7, lines 380-390.
- id: 6c681c04e088
  severity: writing
  text: "Attention map analysis presented as mechanistic evidence for TAR gains, but\
    \ correlation \u2260 causation. Qualitative figures (Fig 6) show attention shifts\
    \ but don't quantify relationship to performance. Remove causal language or add\
    \ quantitative analysis. Section 5.4, lines 1-15."
- id: 590f07f2e3e3
  severity: writing
  text: Claims about healthcare/e-commerce 'high-impact domains' (Introduction) lack
    domain-specific evidence. No medical or e-commerce benchmarks show particular
    advantage over other domains. Either remove or provide domain-stratified analysis.
    Introduction, lines 30-35.
- id: 252aa7cf3eb3
  severity: science
  text: Computational cost analysis shows TAR is 10x slower for text encoders (Appendix
    E2.3) but doesn't discuss cost-benefit tradeoff. For regression tasks with small
    gains (+0.018 mean), is TAR justified? Add cost-efficiency discussion. Section
    6, lines 1-20.
artifact_hash: 6787a87df841d43fd2785f288cbdae2d1c09b5ec14bf84bfd0cf81559d785c80
artifact_path: projects/PROJ-577-multabench-benchmarking-multimodal-tabul/paper/metadata.json
backend: dartmouth
feedback: ''
github_authenticated: false
model_name: qwen.qwen3.5-122b
prompt_version: 1.1.0
reviewed_at: '2026-06-02T11:12:40.477177Z'
reviewer_kind: llm
reviewer_name: paper_reviewer_overreach
score: 0.0
verdict: minor_revision
---

This review focuses exclusively on overreach — claims that extrapolate beyond what the data and methods justify.

**Primary Concerns:**

1. **Circular Benchmark Validation**: The curation pipeline (Section 3.2) selects datasets where TAR already outperforms frozen representations (acceptance criterion: Joint TAR > Joint Frozen). The subsequent claim that TAR "outperforms frozen across all learners" (Section 5) is therefore tautological for the included datasets. The Discussion acknowledges "curation entangles problem with solution" but this limitation significantly constrains the benchmark's ability to make general claims about TAR necessity. The benchmark validates TAR on TAR-suitable datasets, not TAR across all multimodal tabular tasks.

2. **Overstated Generalization**: Claims that gains "generalize across learners, encoder scales, and dimensions" (Abstract, line 12) exceed the experimental scope. Only 5 tabular learners, 2 encoder sizes (384 vs 1024 dim), and 3 PCA configurations (15, 30, 60) were tested. The word "generalize" implies broader applicability than demonstrated.

3. **Mechanistic Interpretation Without Evidence**: Section 5.4 presents attention map shifts (Figure 6) as evidence for why TAR works. However, attention visualization is correlational, not causal. There is no quantitative analysis linking specific attention changes to performance gains. This risks overstating interpretability claims.

4. **Benchmark Size Supertative**: "Largest image-tabular benchmarking effort to date" (Abstract, line 11) requires citation of competing benchmarks with dataset counts. MuG (4 sources), TIME, and MultimodalTabPFN are mentioned but their exact dataset counts are not compared directly.

5. **Domain-Specific Claims Unsubstantiated**: Introduction claims about "high-impact domains (e-commerce, medical)" lack domain-stratified results. Healthcare datasets (CheXpert, Glaucoma, CBIS-DDSM) are included but no analysis shows particular advantage in medical contexts versus general benchmarks.

**Recommendation**: Minor revision to temper claims, add explicit limitations about curation bias, and qualify generalization statements with experimental scope boundaries. The core contribution (benchmark + TAR methodology) is sound but requires more honest framing of what the benchmark can and cannot validate.
